Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Local Delivery of SBRT and IL12 by mRNA Technology Overcomes Immunosuppressive Barriers to Eliminate Pancreatic Cancer.
bioRxiv [Preprint]. 2023 Nov 2:2023.10.30.564833. doi: 10.1101/2023.10.30.564833.
bioRxiv. 2023.
PMID: 37961513
Free PMC article.
Preprint.
CD73 and PD-L1 dual blockade amplifies antitumor efficacy of SBRT in murine PDAC models.
Ye J, Gavras NW, Keeley DC, Hughson AL, Hannon G, Vrooman TG, Lesch ML, Johnston CJ, Lord EM, Belt BA, Linehan DC, Eyles J, Gerber SA.
Ye J, et al. Among authors: vrooman tg.
J Immunother Cancer. 2023 May;11(5):e006842. doi: 10.1136/jitc-2023-006842.
J Immunother Cancer. 2023.
PMID: 37142292
Free PMC article.
Item in Clipboard
Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancer.
Ye J, Mills BN, Qin SS, Garrett-Larsen J, Murphy JD, Uccello TP, Han BJ, Vrooman TG, Johnston CJ, Lord EM, Belt BA, Linehan DC, Gerber SA.
Ye J, et al. Among authors: vrooman tg.
J Immunother Cancer. 2022 Jul;10(7):e004784. doi: 10.1136/jitc-2022-004784.
J Immunother Cancer. 2022.
PMID: 35851308
Free PMC article.
Item in Clipboard
Cite
Cite